New Drug Resistance Index Ranks 41 Countries, Shows Distinctions Between High-, Low-Income Nations

CIDRAP News: New metric aims to simplify how global resistance is measured
“A new method for measuring and tracking antibiotic resistance and comparing the effectiveness of antibiotics by country shows a clear distinction between high- and low-income countries. In a study published in BMJ Global Health, researchers from the Center for Disease Dynamics, Economics & Policy (CDDEP) calculated the Drug Resistance Index (DRI) — which combines measurements of antibiotic consumption and resistance across several disease-causing pathogens — for 41 countries. … DRIs were generally correlated with income levels, with high-income countries such as Sweden, Canada, and Norway having the lowest DRIs and India, Thailand, and Ecuador the highest…” (Dall, 4/18).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.